2023
DOI: 10.1021/acsami.3c01499
|View full text |Cite
|
Sign up to set email alerts
|

Transferrin-Targeted Cascade Nanoplatform for Inhibiting Transcription Factor Nuclear Factor Erythroid 2-Related Factor 2 and Enhancing Ferroptosis Anticancer Therapy

Abstract: Ferroptosis, an iron-dependent cell death driven by the lethal levels of lipid peroxidation (LPO), becomes a promising anticancer strategy. However, the anticancer efficacy of ferroptosis is often hindered by the activation of nuclear factor erythrocyte 2-associated factor 2 (Nrf2), which is an indispensable regulator of the cellular antioxidant balance by preventing the accumulation of intracellular reactive oxygen species (ROS). Herein, we present a rational design of a Tf-targeted cascade nanoplatform TPM@A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…In a study, the researchers used a TF-targeted cascading nanoplatform Tf-PEG-modified mesoporous polydopamine (MPDA)@artesunate/ML385 (AM) based on mesoporous polydopamine, co-encapsulating the ferroptosis-inducing agent ART and the Nrf2-specific inhibitor ML385. This increased intracellular ROS levels, consequently enhancing ferroptosis ( 49 ). In another study, the investigators developed programmable carriers for ART that respond to enzymes and ROS, adjusting their size and charge to increase stability and overcome challenges associated with solid tumors.…”
Section: Artcsmentioning
confidence: 99%
“…In a study, the researchers used a TF-targeted cascading nanoplatform Tf-PEG-modified mesoporous polydopamine (MPDA)@artesunate/ML385 (AM) based on mesoporous polydopamine, co-encapsulating the ferroptosis-inducing agent ART and the Nrf2-specific inhibitor ML385. This increased intracellular ROS levels, consequently enhancing ferroptosis ( 49 ). In another study, the investigators developed programmable carriers for ART that respond to enzymes and ROS, adjusting their size and charge to increase stability and overcome challenges associated with solid tumors.…”
Section: Artcsmentioning
confidence: 99%
“…Transferrin (Tf) and transferrin receptor (TfR) form the Tf-TfR complex [ 28 ]. The Tf-TfR complex transfers Fe 3+ into cells, where it is reduced to Fe 2+ [ 29 ].…”
Section: Ferroptosismentioning
confidence: 99%